LOGOGRAM: Validation of Allergy Care Flowcharts in Primary Care: Experience From Occitanie

ClinicalTrials.gov ID

NCT07631039

Lead Sponsor

University Hospital, MontpellierOTHER

Overall Status

Not yet recruiting

Study Type

Interventional

Phase

Not Applicable

Enrollment

600Estimated

Last Update Posted

Jun 5, 2026Actual

Start Date

Sep 2026Estimated

Primary Completion Date

Sep 2030Estimated

Completion Date

Sep 2030Estimated

Official Title

Validation Des Diagrammes de Flux d'Allergies en Soins Primaires : expérience de la région Occitanie

Brief Summary

This study, aimed at validating decision trees developed through collaboration between general practitioners and allergists, seeks to provide French data to optimize care pathways for patients with allergic diseases from the primary care level and to reduce the delays and negative consequences associated with incorrect diagnoses. Most patients with allergic conditions are initially seen in primary care, often during exacerbations. Although allergies, in their many clinical forms, account for approximately 6-8% of primary care consultations, clinicians frequently receive little or no formal training in this field and may not be fully aware of the latest evidence, associated risks, or appropriate referral pathways. These gaps can significantly affect the quality of care and patients' quality of life, while also contributing to higher morbidity and mortality. In this context, the European Academy of Allergy and Clinical Immunology established a multidisciplinary task force to transform existing allergy guidelines into simple, practical, and accessible tools to facilitate diagnosis and management in primary care. The group developed five decision trees covering asthma, anaphylaxis, drug allergy, food allergy, rhinitis, and urticaria to support primary care physicians and other non-specialists in managing patients with symptoms suggestive of allergic or hypersensitivity reactions. The results of this project will be directly applicable to the daily clinical practice of general practitioners in France and could serve as a model for replication in other regions and countries, although adaptations may be required depending on national healthcare systems.

• Allergy

• Implementation of an innovative tool based around AI-automated decision trees on an application

Ages Eligible for Study

Child (0-17)Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Patients with suspected asthma, anaphylaxis, drug allergy, food allergy, rhinitis and urticaria.
• Patients aged 1 year or older at inclusion, registered with a health insurance plan.
• Patient or legal representative of the minor patient who agrees to participate in the research.

Exclusion Criteria:

• Adults placed under guardianship or curatorship.
• Patients already followed by an allergist and/or a specialist doctor for their allergies.
• Patients who participate in a clinical research study relating to an antiallergic medication, immunosuppressant, immunomodulator in the year preceding their consultation visit with the GP.

Primary Purpose

Diagnostic

Allocation

Non-Randomized

Interventional Model

Sequential Assignment

Masking

None (Open Label)

Lead Sponsor

University Hospital, MontpellierOTHER

agnes.oude-engberink@umontpellier.fr+33426030690

karolina.griffiths@umontpellier.fr+33783452124

jean-baptiste.tostain@umontpellier.fr+33468938819

alexis.vandeventer@umontpellier.fr+33448065260

sylvain.pavageau@umontpellier.fr+33468516033

benedicte.teisserenc@umontpellier.fr+ 33686169 218

drmelissamoreno@outlook.fr!+33411669785

laureferrieres@gmail.com+33467988160

• VALIDATION OF THE CHAPTER "ALLERGIES AND HYPERSENSITIVITY" OF THE INTERNATIONAL DISEASE CLASSIFICATION (CIM)

  NCT03213808

  Unknown statusObservationalUpdated Aug 3, 2017
• Allergology: Information, Data and Knowledge Organization

  NCT04887441

  Unknown statusObservationalUpdated May 14, 2021
• Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice

  NCT04038268

  CompletedObservationalUpdated Dec 29, 2020
• Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy In Southern Europe.

  NCT03636919

  CompletedObservationalUpdated Jul 13, 2023
• Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier

  NCT05112367

  Unknown statusObservationalUpdated Nov 8, 2021
• Towards an Algorithmic Approach to Asthma Management: Collaborative Definition of Algorithm Objectives With Families

  NCT05064579

  CompletedObservationalUpdated Sep 12, 2025